Do exosomes derived from hypoxia-preconditioned MSCs prevent doxorubicin-induced cardiac senescence in human iPSC-derived cardiomyocytes?
Exosomes from hypoxia-preconditioned MSCs attenuate doxorubicin-induced cardiac senescence via the lncRNA-MALAT1/miR-92a-3p/ATG4a pathway, suggesting a potential therapeutic target for chemotherapy-induced cardiomyopathy.
may serve as a potential therapeutic target against DIC.
Xia et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: